ILCN Lung Cancer News
ILCN Lung Cancer News


  • Paul A. Bunn, Jr, MD: Recipient of 2016 Karnofsky Award

    Paul A. Bunn, Jr, MD: Recipient of 2016 Karnofsky Award

    Uncategorized

    The David A. Karnofsky Memorial Award from the American Society of Clinical Oncology (ASCO) recognizes oncologists who have made outstanding contributions to the research, diagnosis, or treatment of cancer. Dr. Paul A. Bunn, Jr, Distinguished Professor, Division of Medical Oncology/ University of Colorado, James Dudley Chair in Lung Cancer Research, is the 2016 Karnofsky Award…


  • Breaking News Briefs

    Breaking News Briefs

    Industry News & Regulatory Approvals

    • Clovis Oncology is shutting down patient enrollment in clinical trials of its lung cancer drug rociletinib, which targets T790m, a mutation responsible for acquired resistance in more than half of those initially treated with firstgeneration TKIs targeting EGFR mutations. This includes the pivotal trial TIGER-3. This decision came after a US FDA panel, ODAC,…


  • Stefania Vallone

    Stefania Vallone

    Names & News

    Stefania Vallone has been elected President of Lung Cancer Europe (LuCE), which provides a European platform for already existing lung cancer patient advocacy groups and supports the establishment of national lung cancer patient groups in different European countries where such groups do not yet exist. Ms. Vallone, Italy, is a lung cancer patient advocate, who…


  • Charles Swanton, MD, PhD

    Charles Swanton, MD, PhD

    Names & News

    Charles Swanton received the Biochemical Society 2016 GSK prize in recognition of distinguished research leading to new advances in medical science. Prof. Swanton is Professor of Cancer Medicine and Chair of Personalized Cancer Medicine, University College London, UK, and Co-Director, Cancer Research UK Lung Cancer Center of Excellence at University College London, and Manchester University, UK.


  • Patrick Soon-Shiong, MD, FRCS (C), FACS

    Patrick Soon-Shiong, MD, FRCS (C), FACS

    Names & News

    Patrick Soon-Shiong has been appointed Chairman of the Board of Directors of Altor BioScience Corporation. Dr. Soon- Shiong is the inventor of Abraxane, an albuminbound nanoparticle of paclitaxel approved for lung, breast, and pancreatic cancer. He announced the Cancer MoonShot 2020 Program in January 2016.


  • Suresh Senan, MRCP, FRCR, PhD

    Suresh Senan, MRCP, FRCR, PhD

    Names & News

    Suresh Senan received the 2016 Heine H. Hansen Award, which recognizes a lung cancer investigator who has made a special contribution to lung cancer research and education on an international basis. Prof. Senan is Vice Chair of the Department of Radiation Oncology at the VU University Medical Centre, Amsterdam, the Netherlands, and is Professor of…


  • Umberto Ricardi, MD

    Umberto Ricardi, MD

    Names & News

    Umberto Ricardi has been elected President- Elect of the European SocieTy for Radiotherapy & Oncology (ESTRO). Prof. Ricardi is Full Professor of Radiation Oncology and Chairman of the Radiation Oncology Department, University of Turin, Turin, Italy.


  • Cathy Pietanza, MD

    Cathy Pietanza, MD

    Names & News

    Cathy Pietanza has been appointed Global Director of Scientific Affairs for Oncology in Merck Research Laboratories. Prior to joining Merck, Dr. Pietanza was an Assistant Attending Physician at Memorial Sloan-Kettering Cancer Center, New York, US, on the Thoracic Oncology Service, and also held an appointment at the Weill Cornell Medical College.


  • Waun Ki Hong, MD, FACP, DMSc (Hon)

    Waun Ki Hong, MD, FACP, DMSc (Hon)

    Names & News

    Waun Ki Hong received the 10th AACR Margaret Foti Award for Leadership and Extraordinary Achievements in Cancer Research and the 2016 ASCO Special Recognition Award, which honors an individual whose research and innovations have had a transforming and lasting effect in the areas of clinical oncology, cancer research, clinical trials, or patient advocacy activities. Dr. Hong…


  • Roman Perez-Soler, MD

    Roman Perez-Soler, MD

    Names & News

    Roman Perez-Soler has been named to the US National Cancer Institute’s (NCI’s) Board of Scientific Counselors for Clinical Sciences and Epidemiology, which provides advice on NCI intramural and extramural research programs. Dr. Perez-Soler is Chairman and Chief, Department of Oncology, Montefiore Einstein Center for Cancer Care; Chief and Professor, Division of Medical Oncology, Department of…